This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

The United States has been the undisputed innovator and leader in biology and biotechnology ... Just as we have experienced with other US innovations, from solar panels and batteries to computer ...

Local biotech Aardvark Therapeutics made its debut on the public market this month, making it San Diego’s first life science IPO of 2025. Aardvark is a clinical stage company developing small molecule ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

Although a federal judge has temporarily blocked the policy change, government grants to early-stage biotech startups could still face delays or be eliminated entirely, said Chris Gibson ...

The deal is worth up to $1.4bn and allows the US drugmaker to start trials using the technology to deliver another Alzheimer’s drug. The biotech, which created the Alzheimer’s medicine ...

Preparations for submission of a Biologics License Application (BLA) for Cylembio® (imsapepimut and etimupepimut, adjuvanted) to FDA by year end ...